title: Pneumonia and bacteremia due to Kytococcus schroeteri.
abstract: Kytococcus schroeteri, a saprophyte of the human skin, may cause serious infections in the immunocompromised host. Here, we describe a case of pneumonia and bacteremia due to Kytococcus schroeteri in an immunocompromised patient, successfully treated with linezolid and trimethoprim-sulfamethoxazole.
authors.affiliation: Department of Medicine, Division of Infectious Diseases, Karolinska Institutet, Karolinska University Hospital, Huddinge, Stockholm, Sweden. ola.blennow@karolinska.se
authors.forename: Ola
authors.initials: O
authors.lastname: Blennow
authors.forename: Katarina
authors.initials: K
authors.lastname: Westling
authors.forename: Inga
authors.initials: I
authors.lastname: Fröding
authors.forename: Volkan
authors.initials: V
authors.lastname: Ozenci
mesh_terms: D000081:Acetamides / Q000008:administration & dosage; D000192:Actinomycetales / Q000302:isolation & purification*; D000193:Actinomycetales Infections / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology / Q000473:pathology; D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D016470:Bacteremia / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology / Q000473:pathology; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D000069349:Linezolid; D023303:Oxazolidinones / Q000008:administration & dosage; D018410:Pneumonia, Bacterial / Q000150:complications* / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology; D016896:Treatment Outcome; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000008:administration & dosage
chemical_list: D000081:Acetamides; D000900:Anti-Bacterial Agents; D023303:Oxazolidinones; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D000069349:Linezolid